Mallinckrodt (MNKTQ) Stock News, Aug 30-31, 2023

MNKTQ OTC

08/31/2023 06:45 AM

News

Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-32.94%

Tags

-

08/30/2023 11:54 AM

News

Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-19.05%

Tags